MVP
SLXP

Missouri Valley Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Missouri Valley Partners’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.14M Buy
16,991
+900
+6% +$62K 0.43% 75
2013
Q2 		$1.06M Buy
+16,091
New +$920K 0.41% 75

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Missouri Valley Partners's SLXP Position: Q3 2013 in Review

Missouri Valley Partners increased its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 5.6% in Q3 2013, buying an estimated $62K and bringing the position to 16,991 shares worth $1.14M. The position accounts for 0.43% of the portfolio, ranked #75.

Missouri Valley Partners first reported a position in SLXP in Q2 2013 and has held it in 2 quarters since. 251 funds tracked by Wall St. Rank hold SLXP as of Q3 2013.

  • Missouri Valley Partners held 16,991 shares of SALIX PHARMACEUTICALS LTD DEL worth $1.14M as of Q3 2013.
  • Missouri Valley Partners bought 900 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2013, an estimated $62K.
  • SALIX PHARMACEUTICALS LTD DEL made up 0.43% of Missouri Valley Partners's portfolio in Q3 2013, its #75 holding.
  • Missouri Valley Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and has held it in 2 quarters since.
  • 251 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2013.

Based on Missouri Valley Partners's 13F filing for Q3 2013, filed 13 Nov 2013.